Bioactivity:

BJE6-106 (B106) is a potent, selective PKC_ inhibitor (IC50: 0.05 _M) and targets selectivity over classical PKC_ (IC50: 50 _M). BJE6-106 induces caspase-dependent apoptosis with tumor-specific effect.

CAS nr:

1564249-38-2

Purity:

98%

Molecular Weight:

381,47

SMILES:

O=CC1=C2C(C=CC(C)(C)O2)=CC(CCN3C4=C(C5=C3C=CC=C5)C=CC=C4)=C1

Formula:

C26H23NO2

Pathway:

Cytoskeletal Signaling,Chromatin/Epigenetic

Target:

PKC,PKC